Redburn Atlantic initiated coverage of Kenvue (KVUE) with a Neutral rating and $23.50 price target The company’s first two years as a public ...

Shares of Kenvue Inc. KVUE advanced 2.81% to $22.71 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.79% to 5,405.97 and the ...

Citi raised the firm’s price target on Kenvue (KVUE) to $22 from $21 and keeps a Neutral rating on the shares as part of a Q1 earnings preview ...

Shares of Kenvue Inc. KVUE advanced 1.01% to $22.09 Friday, on what proved to be an all-around great trading session for the ...

In appraisal of Kenvue’s visual identity, the logo for the independent new company is said to represent Johnson & Johnson’s timelessness, while “allowing space for its iconic brands to have ...

In the latest quarter, 11 analysts provided ratings for Kenvue KVUE, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the ...

Kenvue Inc, a United States-based consumer health company, will deploy more resources to support medical associations and professionals to foster the management of minor ailments in China over the ...